Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccine regimen plus Ad26.ZEBOV booster at 1 year versus 2 years in health-care and front-line workers in the Democratic Republic of the Congo : secondary and exploratory outcomes of an open-label, randomised, phase 2 trial
Bron
The lancet infectious diseases - ISSN 1473-3099- (2024) p. 1-14
Longitudinal assessment of an Ebola vaccine trial understanding among healthcare providers in the Democratic Republic of the Congo
Bron
Vaccine - ISSN 0264-410X-42:3 (2024) p. 481-488
Implementation of lifelong ART (Option B+) for Prevention of Mother-to-Child Transmission (PMTCT) of HIV in Uganda
Bron
Antwerp, University of Antwerp, Faculty of Medicine and Health Sciences, Global Health Institute, 2024,210 p.
Effectiveness and safety of intermittent preventive treatment with dihydroartemisinin-piperaquine or artesunate-amodiaquine for reducing malaria and related morbidities in schoolchildren in Tanzania : a randomised controlled trial
Bron
The Lancet Global Health - ISSN 2214-109X-11:8 (2023) p. E1277-E1289
Evaluation of a community-based intervention package to improve knowledge of obstetric danger signs, birth preparedness, and institutional delivery care utilization in Arba Minch Zuria District, Ethiopia : a cluster-randomized trial
Bron
Reproductive health - ISSN 1742-4755-20:1 (2023) p. 1-13